CrossrefInfokarte
Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies
European Journal of Cancer · 2026-12 · 249 · 117817
DOI: 10.1016/j.ejca.2026.117817 ↗Abstract
Kein Abstract verfügbar.
EUVIMED